C
Claudia Slimings
Researcher at Australian National University
Publications - 21
Citations - 793
Claudia Slimings is an academic researcher from Australian National University. The author has contributed to research in topics: Medicine & Curriculum. The author has an hindex of 7, co-authored 17 publications receiving 655 citations. Previous affiliations of Claudia Slimings include University of Western Australia.
Papers
More filters
Journal ArticleDOI
Antibiotics and hospital-acquired Clostridium difficile infection: update of systematic review and meta-analysis
Claudia Slimings,Thomas V. Riley +1 more
TL;DR: The risk of HA-CDI remains greatest for cephalosporins and clindamycin, and their importance as inciting agents should not be minimized, particularly if fluoroquinolone-resistant epidemic strains of C. difficile are absent.
Journal ArticleDOI
Increasing incidence of Clostridium difficile infection, Australia, 2011-2012
Claudia Slimings,Paul K Armstrong,Wendy Beckingham,Ann L. Bull,Lisa Hall,Karina Kennedy,John Marquess,Rebecca McCann,Andrea Menzies,Brett G Mitchell,Michael J Richards,Paul C Smollen,Lauren Tracey,Irene J Wilkinson,Fiona Wilson,Leon J Worth,Thomas V. Riley +16 more
TL;DR: The quarterly incidence of hospital‐identified Clostridium difficile infection in Australia is reported and the burden ascribed to hospital‐associated and community‐associated infections is estimated.
Journal ArticleDOI
Emergence and spread of predominantly community-onset Clostridium difficile PCR ribotype 244 infection in Australia, 2010 to 2012.
David W Eyre,Lauren Tracey,Briony Elliott,Claudia Slimings,Peter G. Huntington,Rhonda L. Stuart,Tony M. Korman,G. Kotsiou,Rebecca McCann,David Griffiths,W. N. Fawley,Paul K Armstrong,Kate E. Dingle,A S Walker,A S Walker,Tim E. A. Peto,Tim E. A. Peto,Derrick W. Crook,Derrick W. Crook,Mark H. Wilcox,Thomas V. Riley +20 more
TL;DR: Using whole genome sequencing, it is confirmed ribotype 244 is from the same C. difficile clade as the epidemic ribotype 027, which produces toxins A, B, and binary toxin, however it is fluoroquinolone-susceptible and thousands of single nucleotide variants distinct from ribotypes 027.
Journal ArticleDOI
Cytomegalovirus viraemia and mortality in renal transplant recipients in the era of antiviral prophylaxis. Lessons from the western Australian experience
Linda A. Selvey,Wai H. Lim,Peter Boan,Ramyasuda Swaminathan,Claudia Slimings,Amy Harrison,Aron Chakera,Aron Chakera +7 more
TL;DR: A greater vigilance in monitoring CMV levels if antiviral prophylaxis is stopped prematurely or poor patient compliance is suspected could protect some renal transplant recipients from adverse outcomes such as premature mortality.
Journal ArticleDOI
Association of Gestational Age at Birth with Reasons for Subsequent Hospitalisation: 18 Years of Follow-Up in a Western Australian Population Study
TL;DR: Compared with full term born infants, those born at shorter GA remain vulnerable to subsequent hospitalisation for a variety of causes up until 18 years of age.